Search

Non-Insulin-Dependent Diabetes Mellitus (NIDDM) is associated with an increased risk of microvascular complications. Thrombolytic protein therapy may help prevent these complications, but its efficacy remains unclear. We aimed to comprehensively evaluate the role of thrombolytic protein therapy in preventing microvascular complications in NIDDM patients through an integrated analysis of bioinformatics and clinical data. A retrospective cohort study design was utilized. Bioinformatics analysis included transcriptomic profiling, single-nucleotide polymorphism identification, and predictive modeling. Clinical parameters involving patient demographics, medical history, and lab results were collected and analyzed. Transcriptomic analysis identified differentially expressed genes related to microvascular complications, including ABCA1, MMP9, VEGFA, and FN1. Pathway enrichment analysis revealed associations with blood vessel development, extracellular matrix organization, inflammation, and angiogenesis pathways. Single-nucleotide polymorphism analysis identified genetic variants associated with complications. Predictive models achieved high accuracy, sensitivity, and specificity in forecasting individual thrombolytic therapy responses. Clinical data provided insights into population characteristics and comorbidities. The results provide evidence that thrombolytic protein therapy may help prevent microvascular complications in NIDDM patients by modulating molecular pathways and genetic risks. Bioinformatics-guided predictive modeling shows promise for personalized treatment. Further research is needed to validate these findings and optimize thrombolytic protein therapy approaches. [ABSTRACT FROM AUTHOR]

Context: Observational studies have reported lower risks of type 2 diabetes with higher vitamin K1 intake, but these studies overlook effect modification due to known diabetes risk factors. Objective: To identify subgroups that might benefit from vitamin K1 intake, we examined associations between vitamin K1 intake and incident diabetes overall and in subpopulations at risk of diabetes. Methods: Participants from the prospective cohort, the Danish Diet, Cancer, and Health Study, with no history of diabetes were followed up for diabetes incidence. The association between intake of vitamin K1, estimated from a food frequency questionnaire completed at baseline, and incident diabetes was determined using multivariable-adjusted Cox proportional-hazards models. Results: In 54 787 Danish residents with a median (interquartile range) age of 56 (52-60) years at baseline, 6700 individuals were diagnosed with diabetes during 20.8 (17.3-21.6) years of follow-up. Vitamin K1 intake was inversely and linearly associated with incident diabetes (P < .0001). Compared to participants with the lowest vitamin K1 intake (median:57 µg/d), participants with the highest intakes (median:191 µg/d) had a 31% lower risk of diabetes (HR; 95% CI, 0.69; 0.64-0.74) after multivariable adjustments. The inverse association between vitamin K1 intake and incident diabetes was present in all subgroups (namely, men and women, ever and never smokers, low and high physical activity groups, and in participants who were normal to overweight and obese), with differences in absolute risk between subgroups. Conclusion: Higher intake of foods rich in vitamin K1 was associated with a lower risk of diabetes. If the associations observed are causal, our results indicate that more cases of diabetes would be prevented in subgroups at higher risk (men, smokers, participants with obesity, and those with low physical activity). [ABSTRACT FROM AUTHOR]

This study proposes a graph-based method for representing the dynamics of chronic diabetes as a complex process with different characteristics. The study was based on the case histories of6864 patients with diabetes mellitus, 90% of whom suffer from type 2 diabetes. Our method allows to predict the sequence of events during the development of type 2 diabetes for each patient. Typical developmental trajectories of the disease were investigated, their clustering was carried out, the trajectory patterns were identified and studied. Based on the constructed directed graph reflecting transitions between different conditions of the patients, the clustering of diabetic statuses was carried out using the Modularity Class method; 8 clusters were selected, each of them was interpreted and studied. The method of the disease developmental trajectories creation by means of machine learning methods was described. Unlike static models of a disease course, this method considers complete past information on the patient and his or her previous events, using each event of the course of disease to predict the next event. [ABSTRACT FROM AUTHOR]

The main idea of this research is the creation of a new approach to the prediction of chronic diabetes course. This approach is based on dividing patients into several clusters. We used Machine Learning methods for it. Next, we created a diagram of the course of disease in form Markov chains for each cluster of patients. Diagram in form directed graph. Nodes and edges are conditions of patients and transactions between these conditions. Edges values are the probability of transactions. The method based on 7000 histories of diabetes course. A medical specialist can use this method for creating a prediction of diabetes course for a patient. [ABSTRACT FROM AUTHOR]

Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-occur. We reviewed the available evidence from longitudinal and Mendelian randomisation (MR) studies on the relationship between major depressive disorder (MDD), bipolar disorder and T2DM. The clinical implications of this comorbidity on the course of either condition and the impact of antidepressants, mood stabilisers, and antidiabetic drugs were examined. Consistent evidence indicates a bidirectional association between mood disorders and T2DM. T2DM leads to more severe depression, whereas depression is associated with more complications and higher mortality in T2DM. MR studies demonstrated a causal effect of MDD on T2DM in Europeans, while a suggestive causal association in the opposite direction was found in East Asians. Antidepressants, but not lithium, were associated with a higher T2DM risk in the long-term, but confounders cannot be excluded. Some oral antidiabetics, such as pioglitazone and liraglutide, may be effective on depressive and cognitive symptoms. Studies in multi-ethnic populations, with a more careful assessment of confounders and appropriate power, would be important. • There is a bidirectional association between mood disorders and type 2 diabetes (T2DM). • Depression is associated with greater complications and higher mortality in T2DM. • T2DM is associated with chronicity, treatment resistance, and severe symptoms in depression. • Some antidepressants may improve glycaemic control in the short-term. • Thiazolidinediones and incretin analogues may be effective on depressive symptoms. [ABSTRACT FROM AUTHOR]